Reports of the presence of RNA in human plasma have been numerous, often suggesting that RNA in plasma is correlated with human disease. We critically examined the methods for determination of RNA in plasma. Lack of method specificity has caused previous workers to overestimate plasma RNA concentrations by more than 50-fold.
Ribonucleic Acid in Plasma from
Reports of the presence of RNA in human plasma have been numerous, often suggesting that RNA in plasma is correlated with human disease. We critically examined the methods for determination of RNA in plasma. Lack of method specificity has caused previous workers to overestimate plasma RNA concentrations by more than 50-fold.
To isolate RNA from plasma, we used both a phenolchloroform extraction and a modified SchmidtThannhauser procedure. We show that RNA in plasma can be identified and quantified by alkaline hydrolysis of the plasma extract and subsequent separation of the resulting 2'-and 3'-mononucieotides by "high-performance" liquid chromatography. We could not detect RNA in plasma from either apparently healthy, normal adults or multiple myeloma patients, but found 1.1 mg/L in the plasma of a patient with WaldenstrOm's macroglobulinemia. Our method is useful for the specific determination of RNA in plasma and will detect as little as 600 tg/L.
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The presence of RNA and DNA in plasma has been associated with several human disorders (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . DNA in cell-free human plasma has received much attention (1) (2) (3) (4) (5) . However, the existence and possible roles of RNA in cell-free plasma have not been investigated as fully. The presence of RNA in serum or plasma, first suggested by Mandel and Metais (2) , has been reported sporadically (6) (7) (8) (9) (10) (11) (12) (13) .
There is much indirect evidence to suggest that RNA may be found in blood plasma. Virus-related genetic material, including RNA, may be present in the plasma of patients with cancer of the colon or rectum (14) . Involvement of RNA in the processes of phagocytosis, immunoglobulin synthesis, and immune cytolysis has been suggested, and RNA metabolism in leukemia reportedly is abnormal (15) (16) (17) (18) (19) (20) (21) . RNA, administered intravenously, is said to reverse immuno-depression (22) , and anti-RNA antibodies have been isolated from the sera of patients of certain disease groups (23) . An RNA-contaming plasma factor that can stimulate idiopathic immunoglobulin synthesis in vivo and in vitro has been reported (10). The potential for RNA to be present in plasma is sug-gested by many of these reports, but direct chemical proof is lacking. Accurate information on RNA concentrations in plasma might well be useful as a marker of certain disorders.
The reliability and accuracy of fluorometric and chemical methods for measuring plasma DNA have been questioned (3). Experience in our laboratory suggests that there are similar reliability problems with fluorometric and chemical RNA assays as applied to plasma (6) (7) (8) .
Here, we report the use of a classic two-stage extraction with phenol and chloroform to remove RNA from plasma, and our results for 10 apparently healthy adults, seven multiple myeloma patients, and one patient with Waldenstr#{246}m's macroglobulinemia.
Our attempts to extract RNA from the plasma of 10 apparently healthy adults by use of the Schmidt-Thannhauser procedure are also reported. Complications associated with substances that co-extract with RNA and interfere with the identification and quantification of RNA from plasma are discussed. We show that RNA, if present in plasma in concentrations of 600 sg!L or greater, can be identified and quantified by alkaline hydrolysis of the plasma extract and separation and measurement of the resulting 2'-and 3'-mononucleotides by liquid chromatography.
Materials and Methods

Blood Collection
We sampled blood from apparently healthy male volunteers, from seven patients with multiple myeloma, and from a patient with Waldenstrom's macroglobulinemia. The specimens were collected by standard venipuncture into "Vacutainer Tubes," 100 X 16 mm (Becton-Dickinson Co., 'Rutherford, NJ 07070), which contained 14 mg of sodium ethylenediaminetetraacetate (EDTA) and which were promptly placed in crushed ice, unless otherwise indicated.
Two-Stage Extraction of RNA with Phenol and
Phenol-Chloroform Mixture
From blood obtained as described above we separated cell-free plasma within 30 mm of collection, by centrifugation (4 #{176}C, 10 mm, 2000 X g) with use of "Seraclears" to improve the separation. (10) .
After this mixing, the emulsion was broken by centrifugation as above. The aqueous phase was mixed with three volumes of 95% ethanol at -20 #{176}C, and held at -20 #{176}C for 4 h, to precipitate RNA. The precipitate, obtained by centrifugation (-15 #{176}C, 10 mm, 39000 X g), was dissolved in 3.0 mL of sodium chloride solution (154 mmol/L) to yield the plasma extract. For quantification of RNA in this extract, a 1.8-mL portion was combined with 0.20 mL of potassium hydroxide (10 mol/L) and incubated at 50 #{176}C for 16 h, to completely hydrolyze RNA to 2'-and 3'-nucleotides.
After hydrolysis, the solutionwas neutralized with perchloric acid (6.0mol/L), cooled in crushed ice for 15 mm, centrifuged to remove potassium perchlorate, and filtered through an 8.0-ftm (av pore size), 13-mm polycarbonate membrane (Nucleopore Corp., Pleasanton, CA 94566). The filtered sample was then examined for the products of KOH-hydrolyzed RNA-2'-and 3'-nucleoside monophosphates-by liquid chromatography as described below.
The analytical recovery of RNA from plasma by the above procedure was assessed by adding 100 zg of yeast RNA to 20 mL of plasma and then extracting the RNA according to the two-stage procedure described above. A recovery of 100% was established for an RNA standard solution (20 tg of yeast RNA per milliliter of isotonic saline) with the extraction process omitted. The percentage recovery of extracted RNA was determined by comparing the total nucleotide peak areas of hydrolyzed plasma extract and hydrolyzed RNA standard solution.
The recovery of RNA from plasma (n = 6) was 56.8 ± 3.4% (mean ± SD). Figure 1 , A and B, shows typical chromatograms of a hydrolyzed yeast-RNA standard solution and a hydrolyzed extract of yeast-RNA-enriched plasma, respectively. The between-run CV for three hydrolyzed RNA standard solutions was 8.4%. We could detect a minimum of 0.2 sg of RNA as hydrolyzed RNA (2'-and 3'-nucleoside monophosphates) injectedintothe liquidchromatograph.As little as 600 ig of RNA per liter of plasma could be detected by our analysis scheme (20 mL of plasma extracted; 50% extraction efficiency for RNA; extracted RNA dissolved in 3.0 mL volume, 0.1 mL of which was injected into the chromatograph).
Modified Schmidt-Thannhauser Method
Blood was collected and plasma prepared as described above, and 10 aliquots of plasma were stored at -20 #{176}C until analysis. Plasma, 2.0 mL, was mixed for 10 mm with 1.5 mL of cold perchloric acid (0.60 mol/L) at 4 #{176}C to precipitate protein and RNA (24, 25) . The precipitate was sedimented by centrifugation, and washed twice with 3.0-mL aliquots of cold perchioric acid (0.20 mol/L). The precipitate was dissolved in 2.5 mL of potassium hydroxide (0.30 mol/L) and incubated with occasional mixing at 37#{176}C for 1 h, to hydrolyze RNA into acid-soluble short-chain polynucleotides and mononucleotides (6, 7, (24) (25) (26) . The solution was cooled on ice for 5 mm and 0.15 mL of perchioric acid (12 mol/L) was added to precipitate protein, which was removed by centrilugation. The acidic supernate was neutralized with potassium hydroxide (10 mol/L), cooled for 15 mm in crushed ice, centrifuged to remove potassium perchiorate, and then concentrated by lyophilization.
The lyophilized material was dissolved in 0.50 mL of po- perchlorate, filtered,and chromatographed as described below.
Liquid Chromatography
We separated and quantified the nucleotidesresulting from the alkaline hydrolysis of RNA by chromatography on a PXS-1025 SAX high-performance anion-exchange column (Whatman, Inc., Clifton, NJ 07014) at room temperature shown in Figure 1 ,it was necessary to control elution conditions as follows. Ammonium phosphate buffer (750 mmolfL, pH 3.70) was used to regenerate the column for at least 15 mm at the beginning of each day and between each sample run.
Fourteen minutes (±1 mm) before sample injection, the eluent was switched from the strong ammonium phosphate buffer (750 mmol/L, pH 3.70) to a more dilute ammonium phosphate buffer (30 mmolfL, pH 3.70). After the 0.100-mL sample was injected, nucleotides were eluted during the next 15 mm, as illustrated in Figure 1 . Retention times may vary with the chromatographic system used. After elution, the column was cleared and regenerated by again pumping the strong ammonium phosphate buffer through the column for 15 mm.
Fluorometric
Assay We evaluated an RNA quantification method that is based on the enhanced fluorescence of ethidium bromide when it is bound to RNA (8, 13, 27, 28) . 
Results
We examined several extraction schemes in an attempt to finda procedure by which RNA could be isolated from plasma in good yield. The possibility that plasma RNA could be destroyed by endogenous ribonucleases during a standard phenol extraction similar to that described by Kirby (29) prompted our examination of Scherrer and Darnell's extraction method (30) as modified by Chen et al. (10) . The extraction medium utilized in the method of Chen et al. contains several ribonuclease inhibitors, including bentonite and polyvinyl sulfate. An ultraviolet absorbance spectrum of a plasma extract prepared by this method (10) was suggestive of multiple components, including protein ( Figure 2C) .
Our attempts to purify the plasma extract by treatment with proteinase K (EC 3.4.21.14), followed by re-extraction with phenol, resulted in an extract having the absorbance spectrum shown in Figure 2B , indicating the removal of substantialamounts of protein. Although the 260/280 nm absorbance ratio for this material is 1.5, suggestive of partly purified RNA, the absorbance spectrum ( Figure 2B ) is not Figure 2B ). This strongly suggests that the absorbance spectrum of the plasma extract prepared by this method is ascribable to polyvinyl sulfate from the extraction medium rather than to any plasma component. Thus, the criteria used by Chen eta!. (10) to assess the purity of their plasma extracts may not be valid.
Phenol-Chloroform Extraction
The plasma samples from the above-described persons were extracted by the two-stage method, the extracts were hydrolyzed, and the hydrolysates were analyzed by chromatography for 2'-and 3'-mononucleotides.
Small peaks characteristic of mononucleotides were seen in the chromatograms of hydrolyzed extract of plasma from the patient with Waldenstr#{246}m's macroglobulinemia ( Figure 1D ). On the basis of the amount of plasma extracted (22 mL) and assuming a 50% analytical recovery, we calculated the concentration of RNA in the plasma of thispatientto be 1.1mg/L, wellbelow the detection limit of chemical or fluorometric plasma RNA methods. In contrast, no hydrolysate of any of the other plasma extracts exhibited characteristic mononucleotide peaks, although some did exhibit small atypical peaks in the elution region of the 2'-and 3'-mononucleotides.
We established that these atypical peaks were in fact not mononucleotides, and thus were not derived from RNA, in three ways. Firstly, under the defined chromatographic elution scheme we used, the atypical peaks were not eluted in a pattern characteristic of nucleotides as seen in our controls ( Figure 1, A and B) . Secondly, samples were chromatographed three times with the detector set at 250, 260, and 280 nm, respectively. The 250/260 and 280/260 absorbance ratios of these atypical peaks were not characteristic of adenine-, guanine-, uracil-, or cystosine-nucleotides. Thirdly, the atypicalpeaks were unaffected by treatingthe sample with alkalinephosphatase (EC 3.1.3.1), which catalyzes the hydrolysis of nucleotides to nucleosides and inorganic phosphate, thus eliminating the nucleotide peaks in the chromatograms.
In contrast, nucleotide peaks were eliminated from control samples containing hydrolyzed yeast RNA when they were treated with alkaline phosphatase.
A chromatogram of a hydrolyzed plasma extract devoid of mononucleotides is seen in Figure  1C and a chromatogram of a positive hydrolyzed plasma extract is seen in Figure 1D .
The isolation of RNA from plasma by a method not involving phenol (a modification of the Schmidt-Thannhauser method) has been reported (6, 7) . We attempted to isolate RNA from plasma by such a procedure. Ten different plasma extracts obtained by the modified Schmidt-Thannhauser method yielded absorbance spectra typical of protein; a typical spectrum for such an extract is shown in Figure 3 . All such spectra have an absorbance maximum at 280 nm and a minimum of 257 nm. As a control, we prepared a SchmidtThannhauser extract of rat liver, and it exhibited a marked absorbance maximum of 260 nm, a minimum at 230 nm, and a 260/280 nm absorbance ratio of 1.9, all features characteristic of RNA. In addition, a few Schmidt-Thannhauser extracts of normal plasma were reacted with orcinol (31). The absorbance spectrum of each orcinol-treated extract exhibited a peak at 550 nm, which is atypical of RNA. An absorbance peak at 670 nm, characteristic of RNA, was demonstrated in orcinol-treated extracts of rat liver and yeast RNA standards.
Analysisof Schmidt-Thannhauser plasma extracts by the much more sensitive and specific "high-performance" 
FluorometriC Assay
When plasma was subjected to the ethidium bromide-RNA fluorometric assay, there was fluorescence, but it was not decreased after ribonuclease treatment of plasma. Specifically, blood from four normal adults, diluted with buffer as described in Methods, gave fluorescence values (arbitrary units) of 12, 17, 19, and 23, respectively, when mixed with an equal volume of ethidium bromide reagent. However, no fluorescence decrease was observed when each of these plasma samples was incubated with pancreatic ribonuclease for 2 h at 37 #{176}C before the fluorometric assay. Evidently ribonuclease-sensitive RNA is absent from normal plasma. In the fluorometric assay, yeast RNA (100 mg/L) in saline (154 mmol/ L) gave an arbitrary fluorescence value of greater than 80, decreasing to 1.0 after ribonuclease treatment, showing that the fluorometric assay was functioning and that the ribonuclease was active. We also observed that iodoacetate, a putative ribonuclease inhibitor (8, 13) , had no effect on the observed fluorescence, and that plasma specimens (without added RNA) may be processed at either 4 or 25 #{176}C without affecting their fluorescence intensity.
Using the fluorometric assay, we studied the effects of endogenous plasma ribonuclease on RNA by preparing a solu- Proteinase K treatment removes much of the material absorbing in the 260-280 nm region of the spectrum ( Figure 2B) , and results in a spectrum virtually identical to that of polyvinyl sulfate in water (Figure 2A) . We showed that polyvinyl sulfate is distributed into the aqueous phase, precipitated by ethanol, and is present in the extract (which would also contain any extractable RNA). These data suggest that the high absorbance ratios reported by Chen et a!. (10) in plasma extracts may well have been the result of polyvinyl sulfate contamination rather than being produced by any component extracted from plasma. We do not wish to imply that their (10) report of idiopathic immunoglobulin synthesis by normal lymphocytes after exposure to phenol extracts of plasma from multiple myeloma patients is an artifact. However, we suggest that if any RNA is present in the plasma extracts, it is much less than is implied by the 260/280 nm absorbance ratios reported by Chen et al. (10) , and that these ratios have no bearing on the purity of preparations with respect to RNA.
Our liquid-chromatographic analysis of hydrolyzed extracts from 18 plasma samples gave only one chromatogram characteristic of hydrolyzed RNA; this was for plasma from a patient with Waldenstr#{246}m's macroglobulmnemia.
This type of plasma is viscous, making it difficult to separate plasma and cellular components.
Although the results must thus be viewed with caution, they suggest that the concentration of plasma RNA we found may be a characteristic of the disease. Schmidt-Thannhauser extracts of plasma appear to be contaminated with protein ( Figure 3 ). Protein contributes greatly to the extract's absorbance at 260 nm, and some material other than RNA in the extract reacts with orcinol to yield a color that can be mistakenly attributed to RNA. The absorbance spectra of orcinol-treated plasma extracts are unlike the spectra of the RNA-orcinol product. Majumder et al. (32) reported similar problems in estimating the RNA content of another complex protein matrix, milk.
Our results with the fluorometric assay for plasma RNA (8, 13) suggest that it yields inaccurate results. The failure to see a difference in fluorescence after treatment of buffer-diluted plasma with ribonuclease strongly suggests that the fluorescence observed is the result of ethidium bromide's interaction with interfering substances in plasma. In our hands, iodoacetic acid (at the concentration used)
did not inhibit endogenous plasma ribonuclease. The possibility that RNA, present at the time of blood collection, was destroyed by endogenous ribonuclease had to be considered. However, studies with yeast RNA-enriched plasma showed that RNA, although considerably degraded in plasma at 25 #{176}C, is not significantly degraded in plasma kept at 4#{176}C for no longer than 4.5 h. Thus, our practice of promptly cooling and processing blood after it is removed from the test subject makes it unlikely that endogenous RNA was destroyed. Because plasma specimens without added RNA could be processed at either 4 or 25 #{176}C with no effect on ethidium bromide fluorescence, we conclude that no measurable RNA was being destroyed by endogenous ribonuclease in our experimental work.
The concentration of RNA, as of DNA (3), in normal plasma appears to be very low. Various workers (2, 6-8, 13) have reported plasma RNA concentrations ranging from 34.9 to 144 mg of RNA per liter. Our work shows that the lowest of these reported values is at least 58-fold too high, based on our minimum detection level of 0.6 mg of RNA per liter (34.9/0.6 = 58), although RNA may be present in normal plasma in concentrations that are below our detection limit. That RNA is present in some unusual form protected from ribonuclease or unextractable by classic methods, or both, seems unlikely, but is not excluded by our present study.
